We are live on ! Find out more
FMI

F/M Investments Portfolio holdings

AUM $1.97B
1-Year Est. Return 30.33%
This Fund
S&P 500
This Quarter Est. Return
-2.84%
1 Year Est. Return
+30.33%
3 Year Est. Return
+101.46%
5 Year Est. Return
+144.03%
10 Year Est. Return
–
AUM
$2.51B
AUM Growth
-$201M
Cap. Flow
-$78.6M
Cap. Flow %
-3.13%
Top 10 Hldgs %
32.12%
Holding
422
New
23
Increased
129
Reduced
193
Closed
31

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$11.8M
2
C icon
Citigroup
C
+$6.42M
3
BLK icon
Blackrock
BLK
+$5.5M
4
HUBS icon
HubSpot
HUBS
+$4.88M
5
LRCX icon
Lam Research
LRCX
+$4.71M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$18.7M
2
ZTWO icon
F/M 2-Year Investment Grade Corporate Bond ETF
ZTWO
+$18.5M
3
AAPL icon
Apple
AAPL
+$10.2M
4
TFC icon
Truist Financial
TFC
+$9.55M
5
TBIL
F/m US Treasury 3 Month Bill Fund
TBIL
+$6.55M

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 11.09%
3 Financials 10.98%
4 Consumer Discretionary 8.01%
5 Industrials 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKRO
276
DELISTED
Akero Therapeutics
AKRO
$1.16M 0.05%
28,590
-17,188
-38% -$729K
SRPT icon
277
Sarepta Therapeutics
SRPT
$1.77B
$1.15M 0.05%
17,983
+1,059
+6% +$111K
TILT icon
278
FlexShares Morningstar US Market Factors Tilt Index Fund
TILT
$2.26B
$1.14M 0.05%
5,560
– –
ACAD icon
279
Acadia Pharmaceuticals
ACAD
$5.03B
$1.14M 0.05%
68,753
+4,093
+6% +$74.4K
QDF icon
280
FlexShares Quality Dividend Index Fund
QDF
$2.28B
$1.14M 0.05%
16,687
– –
NOBL icon
281
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$12B
$1.11M 0.04%
21,792
– –
NLY icon
282
Annaly Capital Management
NLY
$17.4B
$1.09M 0.04%
53,493
-2,502
-4% -$51.5K
IWD icon
283
iShares Russell 1000 Value ETF
IWD
$83.7B
$1.07M 0.04%
5,678
+913
+19% +$174K
IBND icon
284
State Street SPDR Bloomberg International Corporate Bond ETF
IBND
$463M
$1.05M 0.04%
35,676
– –
TRGP icon
285
Targa Resources
TRGP
$55.1B
$1.04M 0.04%
5,173
– –
NEO icon
286
NeoGenomics
NEO
$2.13B
$1.03M 0.04%
108,773
-17,722
-14% -$221K
GMED icon
287
Globus Medical
GMED
$11.2B
$1.02M 0.04%
+13,991
New +$1.16M
BHVN icon
288
Biohaven
BHVN
$2.21B
$1.02M 0.04%
42,249
+15,911
+60% +$561K
EPC icon
289
Edgewell Personal Care
EPC
$1.31B
$1.01M 0.04%
32,240
-96
-0.3% -$3.02K
ENR icon
290
Energizer
ENR
$1.55B
$968K 0.04%
32,368
-74
-0.2% -$2.37K
KLAC icon
291
KLA
KLAC
$259B
$948K 0.04%
13,940
– –
VGSH icon
292
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$931K 0.04%
15,864
-1,030
-6% -$60.1K
XLK icon
293
State Street Technology Select Sector SPDR ETF
XLK
$124B
$908K 0.04%
8,798
+64
+0.7% +$7.26K
DE icon
294
Deere & Co
DE
$168B
$905K 0.04%
1,929
– –
IEI icon
295
iShares 3-7 Year Treasury Bond ETF
IEI
$17.8B
$897K 0.04%
7,596
-29
-0.4% -$3.38K
DOW icon
296
Dow Inc
DOW
$21.2B
$893K 0.04%
25,568
-8,867
-26% -$341K
ALL icon
297
Allstate
ALL
$67.5B
$891K 0.04%
4,305
-30
-0.7% -$5.84K
REXR icon
298
Rexford Industrial Realty
REXR
$8.19B
$890K 0.04%
22,730
+447
+2% +$17.9K
USHY icon
299
iShares Broad USD High Yield Corporate Bond ETF
USHY
$28.7B
$885K 0.04%
24,036
– –
BIV icon
300
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$879K 0.04%
11,483
+1,395
+14% +$105K
10 11
12
13 14

Similar funds

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return

F/M Investments's Q1 2025 Portfolio in Review

As of Q1 2025, F/M Investments held 422 positions worth $2.51B, down 7.4% from $2.71B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

F/M Investments withdrew a net $78.6M in Q1 2025, closing 31 positions and reducing 193 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $3.08M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

Against the trend, F/M Investments opened a new position in Idexx Laboratories worth $11.4M.

  • F/M Investments's largest Q1 2025 buy was Idexx Laboratories: 27,178 shares worth $11.4M.
  • F/M Investments added most to Palantir in Q1 2025, an estimated $3.23M increase.
  • F/M Investments's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $18.7M.
  • F/M Investments fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $3.08M.
  • F/M Investments's ten largest holdings make up 32% of its $2.51B portfolio in Q1 2025.
  • F/M Investments opened 23 new positions and closed 31 in Q1 2025.
  • F/M Investments's portfolio value fell 7.4% quarter-over-quarter to $2.51B.

Based on F/M Investments's 13F filing for Q1 2025, filed 14 May 2025.